Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XtalPi HoldingsFRA:V0I -1.91%20 EV-to-EBITDA is -217.83 as of Aug. 27, 2026. GuruFocus rates FRA:V0I with a GF Score™ of 20/100. The stock has 7 warning signs investors should review. Among 518 Healthcare Providers & Services companies, XtalPi Holdings ranks worse than 193050% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, XtalPi Holdings's enterprise value is €2,852.53 Mil.
XtalPi Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €-13.10 Mil. Therefore, XtalPi Holdings's EV-to-EBITDA for today is -217.83.
The historical rank and industry rank for XtalPi Holdings's EV-to-EBITDA or its related term are showing as below:
FRA:V0I'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -223.98 Med: -5.7 Max: 152.08
Current: -221.76
During the past 5 years, the highest EV-to-EBITDA of XtalPi Holdings was 152.08. The lowest was -223.98. And the median was -5.70.
FRA:V0I's EV-to-EBITDA is ranked worse than 100% of 518
companies
in the Healthcare Providers & Services industry
Industry Median: 10.545
vs FRA:V0I: -221.76
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
XtalPi Holdings's PE Ratio (TTM) for today is calculated as:
XtalPi Holdings's share price for today is €0.77.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. XtalPi Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €-0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for XtalPi Holdings's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:V0I vs VEEV, BTSG, HQY: EV-to-EBITDA Comparison
For the Health Information Services subindustry, XtalPi Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XtalPi Holdings EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, XtalPi Holdings's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where XtalPi Holdings's EV-to-EBITDA falls into.
XtalPi Holdings's current Enterprise Value is €2,852.53 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. XtalPi Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was €-13.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XtalPi Holdings (FRA:V0I) has a EV-to-EBITDA of -217.83 as of Aug. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on XtalPi Holdings. According to the industry distribution chart, XtalPi Holdings ranks #999999 out of 518 companies in the Healthcare Providers & Services industry.
Is XtalPi Holdings' EV-to-EBITDA too high?
XtalPi Holdings' current EV-to-EBITDA is -217.83. Based on the distribution chart, XtalPi Holdings ranks #999999 out of 518 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, XtalPi Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does XtalPi Holdings' EV-to-EBITDA compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, XtalPi Holdings ranks #999999 out of 518 companies for EV-to-EBITDA. This places XtalPi Holdings in the lower half of its industry. The industry median EV-to-EBITDA is 10.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.55, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on XtalPi Holdings. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XtalPi Holdings's current EV-to-EBITDA is -217.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XtalPi Holdings stock overvalued right now?
XtalPi Holdings (FRA:V0I) has a current EV-to-EBITDA of -217.83. The current EV-to-EBITDA is -217.83. XtalPi Holdings' overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For XtalPi Holdings (FRA:V0I), the current EV-to-EBITDA is -217.83 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
XtalPi Holdings Ltd is a research platform company powered by artificial intelligence (AI) and robotics. It is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. The company combines quantum physics, AI, cloud computing, and large-scale robotics to provide research & development solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and materials industries globally. The company has a single segment that is intelligent robotics solutions and drug discovery solutions (including one-stop drug discovery solutions). The firm generates the majority of its revenue from Drug discovery solutions, and a smaller portion of revenue is derived from AI for Science intelligent solutions.
20GF Score
Get the complete analysis for FRA:V0I
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:V0I has been successfully added to your 
